Hereditary spastic paraplegia: clinical features and pathogenetic mechanisms.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 19007737.
- Also identified by DOI 10.1016/S1474-4422(08)70258-8.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Hereditary spastic paraplegia (HSP) describes a heterogeneous group of genetic neurodegenerative disorders in which the most severely affected neurons are those of the spinal cord. These disorders are characterised clinically by progressive spasticity and weakness of the lower limbs, and pathologically by retrograde axonal degeneration of the corticospinal tracts and posterior columns. In recent years, genetic studies have identified key cellular functions that are vital for the maintenance of axonal homoeostasis in HSP. Here, we describe the clinical and diagnostic features of the various forms of HSP. We also discuss the genes that have been identified and the emerging pathogenic mechanisms.
Medical subject headings
- Central Nervous System
- Genetic Predisposition to Disease
- Nerve Degeneration
- Spastic Paraplegia, Hereditary